...
首页> 外文期刊>Phytotherapy research: PTR >Aged garlic extract improves endothelial function in men with coronary artery disease
【24h】

Aged garlic extract improves endothelial function in men with coronary artery disease

机译:老年大蒜提取物可改善患有冠状动脉疾病的男性的内皮功能

获取原文
获取原文并翻译 | 示例
           

摘要

Endothelium-dependent vasodilation is impaired and predicts the risk of a coronary event in patients with coronary artery disease (CAD). Oxidant stress and increased systemic inflammation may contribute to this endothelial dysfunction. Aged garlic extract (AGE) contains antioxidant compounds and increases nitric oxide production and decreases the output of inflammatory cytokines from cultured cells. The aim of this study was to test the effect of treatment with AGE on brachial artery flow mediated endothelium-dependent dilation (FMD) and circulating markers of oxidative stress and systemic inflammation. The trial included 15 men with angiographically proven CAD in a randomized, placebo-controlled, cross-over design with 2-week treatment and washout periods. During AGE supplementation, FMD increased (44%) significantly (p = 0.04) from the baseline and mainly in men with lower baseline FMD. Levels of FMD at the end of AGE treatment were significantly (p = 0.03) higher compared with the corresponding levels at the end of placebo treatment when the variation in baseline body weight was taken into account. Markers of oxidant stress (plasma oxidized low density lipoprotein and peroxides), systemic inflammation (plasma C-reactive protein ad interleukin-6) and endothelial activation (VCAM-1) did not change significantly during the study. These data suggest that short-term treatment with AGE may improve impaired endothelial function in men with CAD treated with aspirin and a statin. Whether improvement in endothelial function decreases the risk of future cardiovascular events remains to be determined. Copyright (c) 2005 John Wiley & Sons, Ltd.
机译:内皮依赖性血管舒张功能受损,并预测冠心病(CAD)患者发生冠脉事件的风险。氧化应激和全身性炎症增加可能会导致这种内皮功能障碍。老化的大蒜提取物(AGE)包含抗氧化剂化合物,可增加一氧化氮的产生,并减少培养细胞中炎性细胞因子的输出。这项研究的目的是测试AGE治疗对肱动脉血流介导的内皮依赖性扩张(FMD)以及氧化应激和全身性炎症循环标志物的影响。该试验包括15名经血管造影证实的CAD的男性患者,采用随机,安慰剂对照,交叉设计,疗程为2周,冲洗时间为2周。在补充AGE期间,FMD较基线显着增加(44%)(p = 0.04),主要发生在基线FMD较低的男性中。考虑到基线体重的变化,与安慰剂治疗结束时的相应水平相比,AGE治疗结束时的FMD水平显着更高(p = 0.03)。在研究过程中,氧化应激(血浆中氧化的低密度脂蛋白和过氧化物),全身性炎症(血浆C反应蛋白和白介素6)和内皮激活(VCAM-1)的标志物没有明显变化。这些数据表明,AGE短期治疗可能改善阿司匹林和他汀类药物治疗的CAD患者血管内皮功能受损。内皮功能的改善是否降低未来发生心血管事件的风险尚待确定。版权所有(c)2005 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号